Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis

Eldrin F. Lewis, Rui Wang, Naresh Punjabi, Daniel J. Gottlieb, Stuart F. Quan, Deepak L. Bhatt, Sanjay R. Patel, Reena Mehra, Roger S. Blumenthal, Jia Weng, Michael Rueschman, Susan Redline

Research output: Research - peer-reviewArticle

Abstract

Introduction Obstructive sleep apnea (OSA) is associated with impaired health-related quality of life (HRQL). Treatment with continuous positive airway pressure (CPAP) has variable impacts on HRQL, and this may be influenced by patient's tolerance of therapy. The objective is to determine the impact of nocturnal supplemental oxygen (NSO) and CPAP on HRQL compared with healthy lifestyle education (HLSE) in individuals with OSA. Methods Patients with coronary heart disease (CHD) or at least 3 major CHD risk factors with apnea-hypopnea index of 15 to 50 events/h were randomized to CPAP, NSO, or HLSE. Health-related quality of life was assessed using the Short-Form 36, and depression was assessed with Patient Health Questionnaire-9 at baseline and 12 weeks. The treatment effect on HRQL change scores through 12 weeks was assessed using multivariable models adjusting for study site, presence of CHD at baseline, race, and baseline HRQL. Results A total of 318 patients were randomized to 1 of 3 treatment arms with 1:1:1 ratio and 94% completed baseline and follow-up HRQL instruments. Mean Short-Form 36 scores were similar at baseline in all 3 groups ranging from 41.8 ± 12 to 51.6 ± 12 in various domains. In multivariable models, the CPAP group noted a significantly greater improvement than NSO in mental health (+2.33, 95% CI 0.34-4.31, P = .02) and mental composite score (+2.40, 95% CI 0.40-4.41, P = .02). Conversely, the CPAP group noted less improvement than NSO in physical function (−2.68, 95% CI −4.66 to −0.70, P = .008) and physical composite score (−2.17, 95% CI −3.82 to −0.51, P = .01). Compared with HLSE, vitality and Patient Health Questionnaire-9 improved with CPAP but not with NSO. Significant interactions were noted between treatment effects with larger differences in black and sleepy patients. Conclusion These data support the use of CPAP for improving vitality, sleepiness, mental health, social functioning, and depressive symptoms in patients with OSA and established CHD or risk factors. Nocturnal supplemental oxygen may have beneficial effects on perceived physical functioning.

LanguageEnglish (US)
Pages59-67
Number of pages9
JournalAmerican Heart Journal
Volume189
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Continuous Positive Airway Pressure
Obstructive Sleep Apnea
Apnea
Health Status
Coronary Disease
Biomarkers
Quality of Life
Oxygen
Therapeutics
Healthy Lifestyle
Mental Health
Depression
Education
Health
Surveys and Questionnaires
Patient Education

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea : A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis. / Lewis, Eldrin F.; Wang, Rui; Punjabi, Naresh; Gottlieb, Daniel J.; Quan, Stuart F.; Bhatt, Deepak L.; Patel, Sanjay R.; Mehra, Reena; Blumenthal, Roger S.; Weng, Jia; Rueschman, Michael; Redline, Susan.

In: American Heart Journal, Vol. 189, 01.07.2017, p. 59-67.

Research output: Research - peer-reviewArticle

Lewis, Eldrin F. ; Wang, Rui ; Punjabi, Naresh ; Gottlieb, Daniel J. ; Quan, Stuart F. ; Bhatt, Deepak L. ; Patel, Sanjay R. ; Mehra, Reena ; Blumenthal, Roger S. ; Weng, Jia ; Rueschman, Michael ; Redline, Susan. / Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea : A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis. In: American Heart Journal. 2017 ; Vol. 189. pp. 59-67
@article{1dc26100a7be478aba2721a443ab6336,
title = "Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis",
abstract = "Introduction Obstructive sleep apnea (OSA) is associated with impaired health-related quality of life (HRQL). Treatment with continuous positive airway pressure (CPAP) has variable impacts on HRQL, and this may be influenced by patient's tolerance of therapy. The objective is to determine the impact of nocturnal supplemental oxygen (NSO) and CPAP on HRQL compared with healthy lifestyle education (HLSE) in individuals with OSA. Methods Patients with coronary heart disease (CHD) or at least 3 major CHD risk factors with apnea-hypopnea index of 15 to 50 events/h were randomized to CPAP, NSO, or HLSE. Health-related quality of life was assessed using the Short-Form 36, and depression was assessed with Patient Health Questionnaire-9 at baseline and 12 weeks. The treatment effect on HRQL change scores through 12 weeks was assessed using multivariable models adjusting for study site, presence of CHD at baseline, race, and baseline HRQL. Results A total of 318 patients were randomized to 1 of 3 treatment arms with 1:1:1 ratio and 94% completed baseline and follow-up HRQL instruments. Mean Short-Form 36 scores were similar at baseline in all 3 groups ranging from 41.8 ± 12 to 51.6 ± 12 in various domains. In multivariable models, the CPAP group noted a significantly greater improvement than NSO in mental health (+2.33, 95% CI 0.34-4.31, P = .02) and mental composite score (+2.40, 95% CI 0.40-4.41, P = .02). Conversely, the CPAP group noted less improvement than NSO in physical function (−2.68, 95% CI −4.66 to −0.70, P = .008) and physical composite score (−2.17, 95% CI −3.82 to −0.51, P = .01). Compared with HLSE, vitality and Patient Health Questionnaire-9 improved with CPAP but not with NSO. Significant interactions were noted between treatment effects with larger differences in black and sleepy patients. Conclusion These data support the use of CPAP for improving vitality, sleepiness, mental health, social functioning, and depressive symptoms in patients with OSA and established CHD or risk factors. Nocturnal supplemental oxygen may have beneficial effects on perceived physical functioning.",
author = "Lewis, {Eldrin F.} and Rui Wang and Naresh Punjabi and Gottlieb, {Daniel J.} and Quan, {Stuart F.} and Bhatt, {Deepak L.} and Patel, {Sanjay R.} and Reena Mehra and Blumenthal, {Roger S.} and Jia Weng and Michael Rueschman and Susan Redline",
year = "2017",
month = "7",
doi = "10.1016/j.ahj.2017.03.001",
volume = "189",
pages = "59--67",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea

T2 - American Heart Journal

AU - Lewis,Eldrin F.

AU - Wang,Rui

AU - Punjabi,Naresh

AU - Gottlieb,Daniel J.

AU - Quan,Stuart F.

AU - Bhatt,Deepak L.

AU - Patel,Sanjay R.

AU - Mehra,Reena

AU - Blumenthal,Roger S.

AU - Weng,Jia

AU - Rueschman,Michael

AU - Redline,Susan

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Introduction Obstructive sleep apnea (OSA) is associated with impaired health-related quality of life (HRQL). Treatment with continuous positive airway pressure (CPAP) has variable impacts on HRQL, and this may be influenced by patient's tolerance of therapy. The objective is to determine the impact of nocturnal supplemental oxygen (NSO) and CPAP on HRQL compared with healthy lifestyle education (HLSE) in individuals with OSA. Methods Patients with coronary heart disease (CHD) or at least 3 major CHD risk factors with apnea-hypopnea index of 15 to 50 events/h were randomized to CPAP, NSO, or HLSE. Health-related quality of life was assessed using the Short-Form 36, and depression was assessed with Patient Health Questionnaire-9 at baseline and 12 weeks. The treatment effect on HRQL change scores through 12 weeks was assessed using multivariable models adjusting for study site, presence of CHD at baseline, race, and baseline HRQL. Results A total of 318 patients were randomized to 1 of 3 treatment arms with 1:1:1 ratio and 94% completed baseline and follow-up HRQL instruments. Mean Short-Form 36 scores were similar at baseline in all 3 groups ranging from 41.8 ± 12 to 51.6 ± 12 in various domains. In multivariable models, the CPAP group noted a significantly greater improvement than NSO in mental health (+2.33, 95% CI 0.34-4.31, P = .02) and mental composite score (+2.40, 95% CI 0.40-4.41, P = .02). Conversely, the CPAP group noted less improvement than NSO in physical function (−2.68, 95% CI −4.66 to −0.70, P = .008) and physical composite score (−2.17, 95% CI −3.82 to −0.51, P = .01). Compared with HLSE, vitality and Patient Health Questionnaire-9 improved with CPAP but not with NSO. Significant interactions were noted between treatment effects with larger differences in black and sleepy patients. Conclusion These data support the use of CPAP for improving vitality, sleepiness, mental health, social functioning, and depressive symptoms in patients with OSA and established CHD or risk factors. Nocturnal supplemental oxygen may have beneficial effects on perceived physical functioning.

AB - Introduction Obstructive sleep apnea (OSA) is associated with impaired health-related quality of life (HRQL). Treatment with continuous positive airway pressure (CPAP) has variable impacts on HRQL, and this may be influenced by patient's tolerance of therapy. The objective is to determine the impact of nocturnal supplemental oxygen (NSO) and CPAP on HRQL compared with healthy lifestyle education (HLSE) in individuals with OSA. Methods Patients with coronary heart disease (CHD) or at least 3 major CHD risk factors with apnea-hypopnea index of 15 to 50 events/h were randomized to CPAP, NSO, or HLSE. Health-related quality of life was assessed using the Short-Form 36, and depression was assessed with Patient Health Questionnaire-9 at baseline and 12 weeks. The treatment effect on HRQL change scores through 12 weeks was assessed using multivariable models adjusting for study site, presence of CHD at baseline, race, and baseline HRQL. Results A total of 318 patients were randomized to 1 of 3 treatment arms with 1:1:1 ratio and 94% completed baseline and follow-up HRQL instruments. Mean Short-Form 36 scores were similar at baseline in all 3 groups ranging from 41.8 ± 12 to 51.6 ± 12 in various domains. In multivariable models, the CPAP group noted a significantly greater improvement than NSO in mental health (+2.33, 95% CI 0.34-4.31, P = .02) and mental composite score (+2.40, 95% CI 0.40-4.41, P = .02). Conversely, the CPAP group noted less improvement than NSO in physical function (−2.68, 95% CI −4.66 to −0.70, P = .008) and physical composite score (−2.17, 95% CI −3.82 to −0.51, P = .01). Compared with HLSE, vitality and Patient Health Questionnaire-9 improved with CPAP but not with NSO. Significant interactions were noted between treatment effects with larger differences in black and sleepy patients. Conclusion These data support the use of CPAP for improving vitality, sleepiness, mental health, social functioning, and depressive symptoms in patients with OSA and established CHD or risk factors. Nocturnal supplemental oxygen may have beneficial effects on perceived physical functioning.

UR - http://www.scopus.com/inward/record.url?scp=85018309026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018309026&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2017.03.001

DO - 10.1016/j.ahj.2017.03.001

M3 - Article

VL - 189

SP - 59

EP - 67

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -